跳至主要内容
临床试验/NCT03909594
NCT03909594撤回4 期

Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone in Patients With Hip or Femur Fracture: a Double Blind Randomized Clinical Trial (BupiKet)

Antonios Likourezos1 个研究点 分布在 1 个国家开始时间: 2022年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
time to first rescue analgesia post-regional nerve blockade

研究概览

简要总结

The project is meant to evaluate the effect of a combination of medications (Bupivacaine + Ketamine) used in an ultra-sound guided nerve block for patients presenting to the Emergency Department (ED) with hip and/or femur fractures. The goal is to see whether the combination of these two medications will result in greater and longer-lasting pain relief, longer-lasting motor and sensory block and overall less need for opioid rescue analgesia.

详细描述

STUDY DESIGN

Subjects: Patients aged 18 years and older with isolated hip or femur fracture confirmed on x-ray.

DESIGN:

A randomized double-blind prospective superiority trail.

  • Each patient will receive Morphine for analgesia prior to regional nerve block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

This is a randomized double blind study - - All the pharmacist and research manager

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • Presenting with isolated hip or femur fracture confirmed on x-ray.

排除标准

  • Polytrauma
  • Unstable vitals signs
  • Allergy to Bupivacaine or Ketamine
  • Inability to give consent
  • Altered mental status
  • Greater than 100kg
  • Known end stage renal disease or hepatic dysfunction
  • Received > 2 doses of Morphine in ER prior to regional nerve block
  • Patients with failed nerve block (30 minute onset)

研究组 & 干预措施

Nerve Block with Bupivacaine an

Experimental

Patients will receive an ultrasound guided regional nerve block with Bupivacaine (0.5% or 5 mg/ml) 2.5 mg/kg (max dose 175 kg) + Ketamine (50 mg/ml) 2 mg/kg. Each patient will be given a volume of 40 mL - this will be a mixture of Bupivacaine, Ketamine and 0.9% NS to make up the full 40 ml.

干预措施: Bupivacaine (Drug)

Nerve Block with Bupivacaine an

Experimental

Patients will receive an ultrasound guided regional nerve block with Bupivacaine (0.5% or 5 mg/ml) 2.5 mg/kg (max dose 175 kg) + Ketamine (50 mg/ml) 2 mg/kg. Each patient will be given a volume of 40 mL - this will be a mixture of Bupivacaine, Ketamine and 0.9% NS to make up the full 40 ml.

干预措施: Ketamine (Drug)

Nerve Block with Bupivacaine al

Active Comparator

Patients will receive an ultrasound guided regional nerve block with Bupivacaine 0.5% only. Each patient will be given a volume of 40 ml - this will be a mixture of Bupivacaine and 0.9% NS to make up the full volume of 40 mL

干预措施: Bupivacaine (Drug)

结局指标

主要结局

time to first rescue analgesia post-regional nerve blockade

时间窗: 0-24 hours

The difference in time from administration of pain medication to rescue analgesia

次要结局

  • Pain score at 30 minutes(30 minutes)

研究者

发起方
Antonios Likourezos
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Antonios Likourezos

Research Manager; Co-Investigator

Maimonides Medical Center

研究点 (1)

Loading locations...

相似试验